IVERIC bio, Inc.

GOLDMAN SACHS GROUP INC

Report date

6/30/2023

Quarter

2023 Q2

Filed

5/14/2024

Shares

4,222,280

Value ($000)

166,104

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	5/14/2024	166,104	0.0%	4,222,280	6/30/2023
2023 Q1	5/14/2024	24,244	0.0%	996,462	3/31/2023
2022 Q4	5/14/2024	27,350	0.0%	1,277,424	12/31/2022
2022 Q3	5/14/2024	17,999	0.0%	1,003,298	9/30/2022
2022 Q2	5/14/2024	7,338	0.0%	762,811	6/30/2022
2022 Q1	5/16/2022	7,080	0.0%	420,696	3/31/2022
2021 Q4	2/17/2022	6,914	0.0%	413,544	12/31/2021
2021 Q3	1/20/2022	2,996	0.0%	184,487	9/30/2021
2021 Q2	8/13/2021	651	0.0%	103,245	6/30/2021
2021 Q1	5/17/2021	536	0.0%	86,862	3/31/2021
2020 Q4	2/12/2021	5,510	0.0%	797,408	12/31/2020
2020 Q3	11/13/2020	1,958	0.0%	347,197	9/30/2020
2020 Q2	8/12/2020	2,531	0.0%	496,308	6/30/2020
2020 Q1	5/15/2020	465	0.0%	135,268	3/31/2020
2019 Q4	2/14/2020	200	0.0%	23,347	12/31/2019